Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer Disease Clinical Trials Targeting Amyloid
Allison B. Reiss, Natalie Montufar, Joshua DeLeon, et al.
The Neurologist (2021) Vol. 26, Iss. 2, pp. 52-61
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Targeting aging and age-related diseases with vaccines
R. H. Wu, Fei Sun, Weiqi Zhang, et al.
Nature Aging (2024) Vol. 4, Iss. 4, pp. 464-482
Closed Access | Times Cited: 23
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 15
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 51
The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment
Allison B. Reiss, Saba Ahmed, Christopher Dayaramani, et al.
Experimental Gerontology (2022) Vol. 164, pp. 111828-111828
Closed Access | Times Cited: 38
The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review
Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4130-4130
Open Access | Times Cited: 11
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson’s disease
Senthilkumar S. Karuppagounder, Hu Wang, Terence Kelly, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 679
Closed Access | Times Cited: 18
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 15
Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer’s disease
Xin‐Kang Tong, Jessika Royea, Édith Hamel
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 20
Fallacies in Neuroscience: The Alzheimer's Edition
Karl Herrup
eNeuro (2022) Vol. 9, Iss. 1, pp. ENEURO.0530-21.2021
Open Access | Times Cited: 16
Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer’s Disease, and Other Dementias
Helen Ding, Allison B. Reiss, Aaron Pinkhasov, et al.
Medicina (2022) Vol. 58, Iss. 8, pp. 1025-1025
Open Access | Times Cited: 16
The Immune System as a Therapeutic Target for Alzheimer’s Disease
Tarek Zieneldien, Janice Kim, Darrell Sawmiller, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1440-1440
Open Access | Times Cited: 16
Big versus small: The impact of aggregate size in disease
Brianna Hnath, Jiaxing Chen, Joshua Reynolds, et al.
Protein Science (2023) Vol. 32, Iss. 7
Open Access | Times Cited: 6
The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators
Hans J. Moebius, Kevin J. Church
Journal of Alzheimer s Disease (2023) Vol. 92, Iss. 1, pp. 1-12
Open Access | Times Cited: 5
Time perception among people living with and without dementia: A scoping review
Natasha L. Gallant, Chelsea L Russill, Natasha C Taylor, et al.
Dementia (2024) Vol. 23, Iss. 7, pp. 1183-1211
Closed Access | Times Cited: 1
Age-related deficits in working memory in 5xFAD mice in the Hebb-Williams maze
Emre Fertan, Richard E. Brown
Behavioural Brain Research (2022) Vol. 424, pp. 113806-113806
Closed Access | Times Cited: 8
Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer’s Disease
Ryszard Pluta, Sławomir Januszewski, Mirosław Jabłoński
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9174-9174
Open Access | Times Cited: 5
N,N-dimethylacetamide targets neuroinflammation in Alzheimer’s disease in in-vitro and ex-vivo models
Zeng-Hui Wei, Jagadish Koya, Nikita Acharekar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease
Conrad N. Trumbore, Aditya Raghunandan
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 1, pp. 33-59
Open Access | Times Cited: 4
Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis
Ankita Srivastava, Heather A. Renna, Maryann Johnson, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1241-1241
Open Access
The role of massive demographic databases in intractable illnesses: Denomics for dementia
Mark M. Stecker, Morgan R. Peltier, Allison B. Reiss
AIMS Public Health (2022) Vol. 9, Iss. 3, pp. 618-629
Open Access | Times Cited: 3
Intracellular Injection of Brain Extracts from Alzheimer’s Disease Patients Triggers Unregulated Ca2+ Release from Intracellular Stores That Hinders Cellular Bioenergetics
Anna Pensalfini, Abdul Rahim Umar, Charles Glabe, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3630-3630
Open Access | Times Cited: 3
Targeting Calpain-2 for Alzheimer’s Disease Treatment
Amy F.T. Arnsten, Michel Baudry
Medical Research Archives (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 1
A Perspective: Challenges in Dementia Research
Mark M. Stecker
Medicina (2022) Vol. 58, Iss. 10, pp. 1368-1368
Open Access | Times Cited: 1
Evaluating the molecular drivers of physical inactivity and muscle atrophy as initiating factors in cognitive impairment
Nathan R. Kerr
(2023)
Open Access
Intracellular injection of brain extracts from Alzheimer’s disease patients trigger unregulated Ca2+ release from intracellular stores that hinders cellular bioenergetics
Anna Pensalfini, Abdul Rahim Umar, Charles Glabe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1 - Next Page

Scroll to top